These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 22799614

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Model for End-stage Liver Disease score is potentially a useful predictor of hyperkalemia occurrence among hospitalized angiotensin receptor blocker users.
    Sheen SS, Park RW, Yoon D, Shin GT, Kim H, Park IW.
    J Clin Pharm Ther; 2015 Feb; 40(1):48-54. PubMed ID: 25328056
    [Abstract] [Full Text] [Related]

  • 3. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G, Annis IE, Farley JF, Mahendraratnam N, Hickson RP, Stürmer T, Robinson JG.
    Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Onset time of hyperkalaemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring?
    Park IW, Sheen SS, Yoon D, Lee SH, Shin GT, Kim H, Park RW.
    J Clin Pharm Ther; 2014 Feb; 39(1):61-8. PubMed ID: 24262001
    [Abstract] [Full Text] [Related]

  • 6. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ, Gao P, de Zeeuw D, Clase C, Dagenais GR, Sleight P, Lonn E, Teo KT, Yusuf S, Mann JF.
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [Abstract] [Full Text] [Related]

  • 7. No increase in adverse events during aliskiren use among ontario patients receiving angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers.
    Gilbert CJ, Gomes T, Mamdani MM, Hellings C, Yao Z, Garg AX, Wald R, Harel Z, Juurlink DN.
    Can J Cardiol; 2013 May; 29(5):586-91. PubMed ID: 23541666
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
    Surabenjawong U, Thunpiphat N, Chatsiricharoenkul S, Monsomboon A.
    J Med Assoc Thai; 2013 Aug; 96(8):905-10. PubMed ID: 23991595
    [Abstract] [Full Text] [Related]

  • 11. Risk of Osteoporotic Fractures With Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors in Hypertensive Community-Dwelling Elderly.
    Butt DA, Mamdani M, Gomes T, Lix L, Lu H, Tu K, Hypertension Outcome, Surveillance Team.
    J Bone Miner Res; 2014 Nov; 29(11):2483-8. PubMed ID: 24806397
    [Abstract] [Full Text] [Related]

  • 12. Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker.
    Jun HR, Kim H, Lee SH, Cho JH, Lee H, Yim HW, Yoon KH, Kim HS.
    Cardiovasc Ther; 2021 Nov; 2021():5935149. PubMed ID: 33747123
    [Abstract] [Full Text] [Related]

  • 13. Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.
    Bandak G, Sang Y, Gasparini A, Chang AR, Ballew SH, Evans M, Arnlov J, Lund LH, Inker LA, Coresh J, Carrero JJ, Grams ME.
    J Am Heart Assoc; 2017 Jul 19; 6(7):. PubMed ID: 28724651
    [Abstract] [Full Text] [Related]

  • 14. Tolerability of angiotensin-receptor blockers in patients with intolerance to angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis.
    Caldeira D, David C, Sampaio C.
    Am J Cardiovasc Drugs; 2012 Aug 01; 12(4):263-77. PubMed ID: 22587776
    [Abstract] [Full Text] [Related]

  • 15. Use of Renin-Angiotensin System Blockers Increases Serum Potassium in Anuric Hemodialysis Patients.
    Movilli E, Camerini C, Gaggia P, Zubani R, Cancarini G.
    Am J Nephrol; 2018 Aug 01; 48(2):79-86. PubMed ID: 30071530
    [Abstract] [Full Text] [Related]

  • 16. Incidence of and risk factors for newly diagnosed hyperkalemia after hospital discharge in non-dialysis-dependent CKD patients treated with RAS inhibitors.
    Saito Y, Yamamoto H, Nakajima H, Takahashi O, Komatsu Y.
    PLoS One; 2017 Aug 01; 12(9):e0184402. PubMed ID: 28877239
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.